Its administration Pfizer / BioNTech vaccine against COVID-19 for those aged 12 and over was approved today by a committee of the Ministry of Health of Japan.
Until now, this vaccine was allowed for those aged 16 and over, as explained by AMPE.
The move follows approval this month in the US and other countries vaccine of Pfizer / BioNTech in teens.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
